131 related articles for article (PubMed ID: 38841986)
1. Remifentanil-induced hyperalgesia: the current state of affairs.
Vitin AA; Egan TD
Curr Opin Anaesthesiol; 2024 Aug; 37(4):371-378. PubMed ID: 38841986
[TBL] [Abstract][Full Text] [Related]
2. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia.
Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H
Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine prevents remifentanil-induced postoperative hyperalgesia and decreases spinal tyrosine phosphorylation of N-methyl-d-aspartate receptor 2B subunit.
Zheng Y; Cui S; Liu Y; Zhang J; Zhang W; Zhang J; Gu X; Ma Z
Brain Res Bull; 2012 Mar; 87(4-5):427-31. PubMed ID: 22301064
[TBL] [Abstract][Full Text] [Related]
4. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal.
Angst MS; Koppert W; Pahl I; Clark DJ; Schmelz M
Pain; 2003 Nov; 106(1-2):49-57. PubMed ID: 14581110
[TBL] [Abstract][Full Text] [Related]
5. Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain?
Yu EH; Tran DH; Lam SW; Irwin MG
Anaesthesia; 2016 Nov; 71(11):1347-1362. PubMed ID: 27734470
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine via Regulating the Trafficking and Function of Spinal NMDA Receptors as well as PKC and CaMKII Level In Vivo and In Vitro.
Yuan Y; Sun Z; Chen Y; Zheng Y; Xie KL; He Y; Wang Z; Wang GL; Yu YH
PLoS One; 2017; 12(2):e0171348. PubMed ID: 28182698
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen-rich saline prevents remifentanil-induced hyperalgesia and inhibits MnSOD nitration via regulation of NR2B-containing NMDA receptor in rats.
Zhang L; Shu R; Wang H; Yu Y; Wang C; Yang M; Wang M; Wang G
Neuroscience; 2014 Nov; 280():171-80. PubMed ID: 25241067
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Nefopam Infusion during Laparascopic Cholecystectomy on Postoperative Pain.
Kim EM; Jeon JH; Chung MH; Choi EM; Baek SH; Jeon PH; Lee MH
Int J Med Sci; 2017; 14(6):570-577. PubMed ID: 28638273
[No Abstract] [Full Text] [Related]
9. Low-dose buprenorphine infusion to prevent postoperative hyperalgesia in patients undergoing major lung surgery and remifentanil infusion: a double-blind, randomized, active-controlled trial.
Mercieri M; Palmisani S; De Blasi RA; D'Andrilli A; Naccarato A; Silvestri B; Tigano S; Massullo D; Rocco M; Arcioni R
Br J Anaesth; 2017 Oct; 119(4):792-802. PubMed ID: 29121294
[TBL] [Abstract][Full Text] [Related]
10. Failure of intrathecal ketorolac to reduce remifentanil-induced postinfusion hyperalgesia in humans.
Eisenach JC; Tong C; Curry RS
Pain; 2015 Jan; 156(1):81-87. PubMed ID: 25599304
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3β contributes to remifentanil-induced postoperative hyperalgesia via regulating N-methyl-D-aspartate receptor trafficking.
Yuan Y; Wang JY; Yuan F; Xie KL; Yu YH; Wang GL
Anesth Analg; 2013 Feb; 116(2):473-81. PubMed ID: 23267003
[TBL] [Abstract][Full Text] [Related]
12. Spinal ephrinB/EphB signalling contributed to remifentanil-induced hyperalgesia via NMDA receptor.
Xia WS; Peng YN; Tang LH; Jiang LS; Yu LN; Zhou XL; Zhang FJ; Yan M
Eur J Pain; 2014 Oct; 18(9):1231-9. PubMed ID: 24737575
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans.
Koppert W; Sittl R; Scheuber K; Alsheimer M; Schmelz M; Schüttler J
Anesthesiology; 2003 Jul; 99(1):152-9. PubMed ID: 12826855
[TBL] [Abstract][Full Text] [Related]
14. No evidence for the development of acute analgesic tolerance during and hyperalgesia after prolonged remifentanil administration in mice.
Ishii H; Petrenko AB; Kohno T; Baba H
Mol Pain; 2013 Mar; 9():11. PubMed ID: 23497285
[TBL] [Abstract][Full Text] [Related]
15. Magnesium sulphate attenuate remifentanil-induced postoperative hyperalgesia via regulating tyrosine phosphorylation of the NR
Sun J; Lin H; He G; Lin W; Yang J
BMC Anesthesiol; 2017 Feb; 17(1):30. PubMed ID: 28222697
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DOR prevents remifentanil induced postoperative hyperalgesia through regulating the trafficking and function of spinal NMDA receptors in vivo and in vitro.
Wang C; Li Y; Wang H; Xie K; Shu R; Zhang L; Hu N; Yu Y; Wang G
Brain Res Bull; 2015 Jan; 110():30-9. PubMed ID: 25498394
[TBL] [Abstract][Full Text] [Related]
17. Ketamine reduces remifentanil-induced postoperative hyperalgesia mediated by CaMKII-NMDAR in the primary somatosensory cerebral cortex region in mice.
Qi F; Liu T; Zhang X; Gao X; Li Z; Chen L; Lin C; Wang L; Wang ZJ; Tang H; Chen Z
Neuropharmacology; 2020 Jan; 162():107783. PubMed ID: 31541650
[TBL] [Abstract][Full Text] [Related]
18. Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans.
Lenz H; Raeder J; Draegni T; Heyerdahl F; Schmelz M; Stubhaug A
Pain; 2011 Jun; 152(6):1289-1297. PubMed ID: 21396775
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord.
Liu X; Liu Y; Zhang J; Zhang W; Sun YE; Gu X; Ma Z
Brain Res Bull; 2014 Jul; 106():9-16. PubMed ID: 24769228
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine.
Gu X; Wu X; Liu Y; Cui S; Ma Z
Mol Pain; 2009 Dec; 5():76. PubMed ID: 20042082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
